ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Operating income 2018–2025
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) annual operating income history from SEC filings — each fiscal year as reported.
-$12.2MFY2025 · since FY2018: -$19.7M → -$12.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.2M | +90.5% |
| FY2024 | -$128.4M | +46.7% |
| FY2023 | -$241.1M | +20.1% |
| FY2022 | -$301.6M | -46.0% |
| FY2021 | -$206.5M | -51.1% |
| FY2020 | -$136.6M | -216.8% |
| FY2019 | -$43.1M | -118.6% |
| FY2018 | -$19.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ARQT financial trends
ARQT RevenueARQT Net incomeARQT Net marginARQT Gross profitARQT Gross marginARQT Operating marginARQT Operating cash flowARQT Free cash flowARQT Capital expendituresARQT Return on equityARQT Stock buybacksARQT Dividends paidARQT Total assetsARQT Total liabilitiesARQT Shareholders’ equityARQT overview →